COPD International   Your Support Network

You can learn to control this disease instead of letting it control you!

 

Return To The Main Library         <<<<>>>>         Return To The HomePage

 
 
SafetyAlerts
June 6, 2002

Boehringer Ingelheim Pharmaceuticals, Inc. Has Recalled Combivent Inhalation Aerosol

The Food and Drug Administration (FDA) said Boehringer Ingelheim Pharmaceuticals, Inc. has recalled Combivent Inhalation Aerosol.

PRODUCT
Combivent Inhalation Aerosol (ipratropium bromide 18 mcg and albuterol sulfate 103 mcg) 14.7g canister, 200 metered actuations, Rx only. Recall
# D-283-2.

CODE
Lot Numbers:
165090A, Exp. Date May-03
165092A, Exp. Date May-03.

RECALLING FIRM/MANUFACTURER
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, by FED EX on May 21, 2002. Firm initiated recall is ongoing.

REASON
Defective container; inhaler may not fire properly and patients will not receive their full dose of medication.

VOLUME OF PRODUCT IN COMMERCE
192,089 units total.

DISTRIBUTION
Nationwide.

Send mail to: Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified:
November 17, 2002
Disclaimer